Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|April 11, 2021
Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrinRobyn T Rebbeck, Anna K Andrick, Sarah A Denha, et al.
Nature Communications|November 9, 2017
Structural basis for high-affinity actin binding revealed by a β-III-spectrin SCA5 missense mutationAdam W Avery, Michael E Fealey, Fengbin Wang, et al.
Molecular Biology of the Cell|October 3, 2008
The scaffold protein POSH regulates axon outgrowthJennifer Taylor, Kwan-Ho Chung, Claudia Figueroa, et al.
The Journal of Biological Chemistry|June 8, 2025
Molecular consequences of SCA5 mutations in the spectrin-repeat domains of β-III-spectrinSarah A Denha, Naomi R DeLaet, Abeer W Abukamil, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Impaired motor activity in a CRISPR SCA5 L253P knock-in mouse is associated with selective β-III-spectrin subcellular redistribution in the cerebellumAdam W Avery, Brennon L O'Callaghan, Matthew T Thiel, et al.
The Journal of Biological Chemistry|February 2, 2023
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5Piyali Guhathakurta, Robyn T Rebbeck, Sarah A Denha, et al.
Pageof 2